Spiroindane based amides as potent and selective MC4R agonists for the treatment of obesity.
暂无分享,去创建一个
Howard Y. Chen | R. Nargund | M. Wyvratt | C. Tamvakopoulos | Yingjie Lai | R. Bakshi | T. Macneil | T. Fong | Jian Liu | I. Sebhat | R. Tang | D. Weinberg | Q. Hong | James P Dellureficio | R. Stearns | Randy R Miller | Airu S. Chen | Tianying Jian | Z. Ye | A. Strack | Qianping Peng | Shuwen He | Liangqin Guo | Peter H. Dobbelaar | C. Franklin
[1] D. Macintyre,et al. Discovery of a spiroindane based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor agonist. , 2010, Bioorganic & medicinal chemistry letters.
[2] Julie A Farmer,et al. Discovery of orally bioavailable 1,3,4-trisubstituted 2-oxopiperazine-based melanocortin-4 receptor agonists as potential antiobesity agents. , 2008, Journal of medicinal chemistry.
[3] J. Huber,et al. Synthesis and SAR of potent and orally bioavailable tert-butylpyrrolidine archetype derived melanocortin subtype-4 receptor modulators. , 2008, Bioorganic & medicinal chemistry letters.
[4] Michael S. Wood,et al. The 1,4-benzodiazepine-2,5-dione small molecule template results in melanocortin receptor agonists with nanomolar potencies. , 2008, Journal of medicinal chemistry.
[5] Xue‐Wei Liu,et al. Synthesis and biological activity of novel peptide mimetics as melanocortin receptor agonists. , 2008, Bioorganic & medicinal chemistry letters.
[6] F. Ujjainwalla,et al. Small molecule ligands of the human melanocortin-4 receptor. , 2007, Current topics in medicinal chemistry.
[7] P. Ornstein,et al. Privileged structure based ligands for melanocortin receptors--4,4-disubstituted piperidine derivatives. , 2006, Bioorganic & medicinal chemistry letters.
[8] R. Nargund,et al. Melanocortin-4 receptor (MC4R) agonists for the treatment of obesity. , 2006, Journal of medicinal chemistry.
[9] R. Cone. Studies on the physiological functions of the melanocortin system. , 2006, Endocrine reviews.
[10] M. Hadley. Discovery that a melanocortin regulates sexual functions in male and female humans , 2005, Peptides.
[11] F. Ujjainwalla,et al. Design and syntheses of melanocortin subtype-4 receptor agonists. Part 2: discovery of the dihydropyridazinone motif. , 2005, Bioorganic & medicinal chemistry letters.
[12] J. Metzger,et al. Discovery of (2S)-N-[(1R)-2-[4-cyclohexyl-4-[[(1,1-dimethylethyl)amino]carbonyl]-1-piperidinyl]-1-[(4-fluorophenyl)methyl]-2-oxoethyl]-4-methyl-2-piperazinecarboxamide (MB243), a potent and selective melanocortin subtype-4 receptor agonist. , 2005, Bioorganic & medicinal chemistry letters.
[13] H. Bays. Current and investigational antiobesity agents and obesity therapeutic treatment targets. , 2004, Obesity research.
[14] C. Harmon,et al. Recent developments in our understanding of melanocortin system in the regulation of food intake , 2003, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[15] I. Gantz,et al. The melanocortin system. , 2003, American journal of physiology. Endocrinology and metabolism.
[16] D. Johnston,et al. Design and pharmacology of N-[(3R)-1,2,3,4-tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonist. , 2002, Journal of medicinal chemistry.
[17] Christopher P Austin,et al. A role for the melanocortin 4 receptor in sexual function , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[18] M. Bednarek,et al. Selective, high affinity peptide antagonists of alpha-melanotropin action at human melanocortin receptor 4: their synthesis and biological evaluation in vitro. , 2001, Journal of medicinal chemistry.
[19] Yue Feng,et al. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass , 2000, Nature Genetics.
[20] D. Macneil,et al. Molecular analysis of a new splice variant of the human melanocortin‐1 receptor , 1999, FEBS letters.
[21] M. Bednarek,et al. Structure-function studies on the cyclic peptide MT-II, lactam derivative of α-melanotropin☆ ☆ Throughout this report, the numbering of the amino acid residues in α-MSH has been retained for all linear and cyclic peptides. , 1999, Peptides.
[22] S. O’Rahilly,et al. A frameshift mutation in MC4R associated with dominantly inherited human obesity , 1998, Nature Genetics.
[23] K. Clément,et al. A frameshift mutation in human MC4R is associated with a dominant form of obesity , 1998, Nature Genetics.
[24] R. Cone,et al. Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice , 1997, Cell.
[25] S. Hoare,et al. Identification and characterization of pyrrolidine diastereoisomers as potent functional agonists and antagonists of the human melanocortin-4 receptor. , 2008, Bioorganic & medicinal chemistry letters.
[26] Chen Chen. Recent progress toward nonpeptide ligands for the melanocortin-4 receptor. , 2007, Progress in medicinal chemistry.